en
Scientific article
English

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations

Published inAntimicrobial Agents and Chemotherapy, vol. 62, no. 4
Publication date2018
Abstract

Optimal dosing of gentamicin in neonates is still a matter of debate despite its common use. We identified gentamicin dosing regimens from eight international guidelines and seven Swiss neonatal intensive care units. The dose per administration, the dosing interval, the total daily dose, and the demographic characteristics between guidelines were compared. There was considerable variability with respect to dose (4 to 6 mg/kg), dosing interval (24 h to 48 h), total daily dose (2.5 to 6 mg/kg/day), and patient demographic characteristics that were used to calculate individualized dosing regimens. A model-based simulation study in 1071 neonates was performed to determine the achievement of efficacious peak gentamicin concentrations according to predefined MICs (Cmax/MIC ≥ 10) and safe trough concentrations (Cmin ≤ 2 mg/liter) with recommended dosing regimens. MIC targets of 0.5 and 1 mg/liter were used. Dosing optimization was performed giving priority to the first day of treatment and with the goal of simplifying dosing. Current gentamicin neonatal guidelines allow to achieve effective peak concentrations for MICs ≤ 0.5 mg/liter but not higher. Model-based simulations indicate that to attain peak gentamicin concentrations of ≥10 mg/liter, a dose of 7.5 mg/kg should be administered using an extended dosing interval regimen. Trough concentrations of ≤2 mg/liter can be maintained with a dosing interval of 36 to 48 h in neonates according to gestational and postnatal age. For treatment beyond 3 days, therapeutic drug monitoring is advised to maintain adequate serum concentrations.

Citation (ISO format)
VAN DONGE, Tamara et al. Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations. In: Antimicrobial Agents and Chemotherapy, 2018, vol. 62, n° 4. doi: 10.1128/AAC.02004-17
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0066-4804
364views
0downloads

Technical informations

Creation11/14/2018 12:25:00 PM
First validation11/14/2018 12:25:00 PM
Update time03/15/2023 3:50:43 PM
Status update03/15/2023 3:50:42 PM
Last indexation01/17/2024 5:05:11 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack